• Health & Medicine

Smoking among young adults increased by 25% during first lockdown

Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown. Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown.

25 August 2021

• Science & Technology
• Health & Medicine

Cancer Research UK reports record levels of investment in its spinouts

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year. The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

24 August 2021

• Health & Medicine
• Science & Technology

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

13 August 2021

• Health & Medicine

New drug combo for advanced breast cancer approved for NHS in England

People with a certain type of advanced breast cancer will now have routine access to a new treatment option in England. People with a certain type of advanced breast cancer will now have routine access to a new treatment option in England.

13 August 2021

• Health & Medicine

New option to treat advanced oesophageal cancer approved for NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer. The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer.

11 August 2021

• Charity News

Our sun safety messaging tours the UK with the NIVEA Sun Safety Roadshow

9 August 2021

• Health & Medicine

Patients less likely to rate cancer care as 'very good' during pandemic

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK.

5 August 2021

• Health & Medicine

England: Smoking responsible for twice as many cancers in most deprived groups

Over 11,000 cases of cancer were linked to smoking in the lowest income group, compared to around 6,000 in the highest. Over 11,000 cases of cancer were linked to smoking in the lowest income group, compared to around 6,000 in the highest.

3 August 2021

• Health & Medicine

UK sunburn risk: Third of adults more likely to protect their skin abroad than at home

The YouGov survey also revealed that around a fifth of adults (19%) said they’re planning to spend more time outside in the sun in the UK this year. The YouGov survey also revealed that around a fifth of adults (19%) said they’re planning to spend more time outside in the sun in the UK this year.

2 August 2021

• Science & Technology

Scientists developing urine and blood tests to detect brain tumours

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma. Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

23 July 2021

• Health & Medicine

First treatment approved in England for advanced bile duct cancer

The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy. The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.

22 July 2021

• Charity News

Charity ‘looks to the future with renewed optimism’

Cancer Research UK's Annual Report and Accounts 2020/21 reveals the impact of the pandemic on its income and spend on charitable activities over the past year. Cancer Research UK's Annual Report and Accounts 2020/21 reveals the impact of the pandemic on its income and spend on charitable activities over the past year.

21 July 2021